迅速診断の世界市場：製品・プラットフォーム・用途・エンドユーザー別 - 2029年までの予測

世界の迅速診断の市場規模は、2029年までに264億米ドルに達し、2022年～2029年にかけてCAGRで1.4％の成長が予測されています。POC診断に対する需要の向上、高齢者人口の増加に伴う慢性疾患の流行、救急医療における迅速な意思決定の必要性の高まり、新たな技術革新などが、市場の成長を促進する要因となっています。

当レポートでは、世界の迅速診断市場について調査分析し、市場考察、製品別分析、地域別分析、競合情勢などを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場考察

• 市場概要
• 促進要因
  • 高齢者人口の増加に伴う慢性疾患の流行
  • 感染症の流行
  • 迅速な意思決定の必要性の高まり
  • POC診断に対する需要の向上
  • 技術革新
• 抑制要因
  • 検査結果の相違
• 市場機会
  • 新興市場
• 課題
  • 既存の診断方法の変更に対する消極性
• 迅速診断市場に対するCOVID-19の影響
• 薬事申請（RA）分析
  • 米国
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
• 迅速診断：革新と今後の技術

第5章 世界の迅速診断市場：製品別

• イントロダクション
• キット
  • プロフェッショナルキット
  • OTCキット
• 装置

第6章 世界の迅速診断市場：プラットフォーム別

• イントロダクション
• 免疫検査
  • ラテラルフローアッセイ
  • 血清検査
  • その他の免疫検査
• 分子検出検査
• その他の迅速診断プラットフォーム

第7章 世界の迅速診断市場：用途別

• イントロダクション
• 感染症検査
  • COVID-19検査
  • 医療関連感染症（HAI）検査
  • 肝炎検査
  • 熱帯病検査
  • HIV検査
  • 呼吸器疾患検査（インフルエンザとCOVID-19を除く）
  • インフルエンザ検査
  • 性感染症（STD）検査
  • その他の感染症検査
• 妊娠・受胎検査
• 心臓代謝検査
• コレステロール検査
• 腫瘍/がんマーカー検査
• 血糖値検査
• 尿検査
• 血液検査
• その他の検査

第8章 迅速診断市場：エンドユーザー別

• イントロダクション
• 病院・診療所
• 診断研究所
• 在宅ケア/セルフ検査
• その他のエンドユーザー

第9章 迅速診断市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州（RoE）
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋（RoAPAC）
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• イントロダクション
• 主要な成長戦略
• 競合ベンチマーキング
• 市場シェア分析（2021年）
  • Abbott Laboratories（米国）
  • Becton, Dickinson and Company（米国）
  • F. Hoffmann-La Roche Ltd.（スイス）

第11章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略的開発）

• Abbott Laboratories
• Becton, Dickinson and Company（BD）
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• ACON Laboratories, Inc.
• Creative Diagnostics
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• BioMerieux S.A.
• Alfa Scientific Designs, Inc.
• BTNX Inc.
• Meridian Bioscience, Inc.
• Trinity Biotech plc

第12章 付録

List of Tables

• Table 1 Rapid Diagnostics Market: Impact Analysis of Market Drivers (2022-2029)
• Table 2 Diabetes Prevalence in People Aged 65 Years and Above, by Region (2017 Vs. 2019 Vs. 2030)
• Table 3 Number of People Aged 65 Years and Above, by Region, 2019 Vs. 2050 (in Million)
• Table 4 Rapid Diagnostics Market: Impact Analysis of Market Restraints (2022-2029)
• Table 5 Percentage of Population Residing in Urban Areas (Emerging Countries)
• Table 6 Some of the Emergency Use Authorizations (EUAs) Granted for Rapid Diagnostics During the COVID-19 Pandemic
• Table 7 Global Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 8 Global Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 9 Global Rapid Diagnostic Kits Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 10 Global Professional Rapid Diagnostic Kits Market Size, by Country/Region, 2022-2029 (USD Million)
• Table 11 Prevalence of Diabetes, by Region, 2019-2045 (in Million)
• Table 12 Global OTC Rapid Diagnostic Kits Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 13 Key Companies Offering Test Readers/Analyzers
• Table 14 Global Rapid Diagnostics Equipment Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 15 Global Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 16 Global Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 17 Global Immunoassays Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 18 Recently Launched Lateral Flow Assays Kits for COVID-19 Testing
• Table 19 Key Companies Offering Lateral Flow Assays
• Table 20 Global Lateral Flow Assays Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 21 Key Companies Offering Serological Tests
• Table 22 Global Serological Tests Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 23 Global Other Immunoassays Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 24 Top Countries with the Highest Search Volume Index for Reverse Transcription-Polymerase Chain Reaction Tests (2020-2021)
• Table 25 Key Companies Offering Rapid Pcr Test Kits
• Table 26 Global Molecular Detection Tests Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 27 Global Other Rapid Diagnostic Platforms Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 28 Global Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 29 Global Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 30 Key Companies Offering Rapid Diagnostic Kits for Infectious Diseases Testing
• Table 31 Global Rapid Diagnostics Market Size for Infectious Diseases Testing, By Country/Region, 2020-2029 (USD Million)
• Table 32 Some of the Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection
• Table 33 Global Rapid Diagnostics Market Size for COVID-19 Testing, Country/Region, 2020-2029 (USD Million)
• Table 34 Global Rapid Diagnostics Market Size for Healthcare-Associated Infections (HAI) Testing, by Country/Region, 2020-2029 (USD Million)
• Table 35 Global Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 36 Global Rapid Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2020-2029 (USD Million)
• Table 37 Global Rapid Diagnostics Market Size for Hepatitis B Testing, by Country/Region, 2020-2029 (USD Million)
• Table 38 Global Rapid Diagnostics Market Size for Hepatitis C Testing, by Country/Region, 2020-2029 (USD Million)
• Table 39 Incidence of Tropical Diseases (2019)
• Table 40 Global Rapid Diagnostics Market Size for Tropical Diseases Testing, By Country/Region, 2020-2029 (USD Million)
• Table 41 HIV Prevalence by Region (2020)
• Table 42 Global Rapid Diagnostics Market Size for HIV Testing, by Country/Region, 2020-2029 (USD Million)
• Table 43 Global Rapid Diagnostics Market Size for Respiratory Diseases Testing, By Country/Region, 2020-2029 (USD Million)
• Table 44 Global Rapid Diagnostics Market Size for Influenza Testing, by Country/Region, 2020-2029 (USD Million)
• Table 45 Global Rapid Diagnostics Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2020-2029 (USD Million)
• Table 46 Global Rapid Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2020-2029 (USD Million)
• Table 47 Countries with High Fertility Rates
• Table 48 Key Companies Offering Rapid Diagnostic Kits for Pregnancy & Fertility Testing
• Table 49 Global Rapid Diagnostics Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020-2029 (USD Million)
• Table 50 Key Companies Offering Rapid Diagnostic Kits for Cardiac Metabolism Testing
• Table 51 Global Rapid Diagnostics Market Size for Cardiac Metabolism Testing, by Country/Region, 2020-2029 (USD Million)
• Table 52 Global Rapid Diagnostics Market Size for Cholesterol Testing, by Country/Region, 2020-2029 (USD Million)
• Table 53 Key Companies Offering Tumor/Cancer Marker Testing Products
• Table 54 Global Rapid Diagnostics Market Size for Tumor/Cancer Markers Testing, By Country/Region, 2020-2029 (USD Million)
• Table 55 Number of People with Diabetes Aged 20-79 Years, by Region, 2019 Vs. 2030 Vs. 2045 (in Million)
• Table 56 Global Rapid Diagnostics Market Size for Blood Glucose Testing, By Country/Region, 2020-2029 (USD Million)
• Table 57 Global Rapid Diagnostics Market Size for Urinalysis, by Country/Region, 2020-2029 (USD Million)
• Table 58 Global Rapid Diagnostics Market Size for Hematology Testing, by Country/Region, 2020-2029 (USD Million)
• Table 59 Global Rapid Diagnostics Market Size for Other Tests, by Country/Region, 2020-2029 (USD Million)
• Table 60 Global Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 61 Global Rapid Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020-2029 (USD Million)
• Table 62 Global Rapid Diagnostics Market Size for Diagnostic Laboratories, By Country/Region, 2020-2029 (USD Million)
• Table 63 Global Rapid Diagnostics Market Size for Home Care/Self-Testing, By Country/Region, 2020-2029 (USD Million)
• Table 64 Global Rapid Diagnostics Market Size for Other End Users, by Country/Region, 2020-2029 (USD Million)
• Table 65 Global Rapid Diagnostics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 66 North America: Rapid Diagnostics Market Size, by Country, 2020-2029 (USD Million)
• Table 67 North America: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 68 North America: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 69 North America: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 70 North America: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 71 North America: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 72 North America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020-2029 (USD Million)
• Table 73 North America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 74 North America: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 75 Rapid Diagnostic Kits Launched for Coronavirus Testing
• Table 76 U.S.: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 77 U.S.: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 78 U.S.: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 79 U.S.: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 80 U.S.: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 81 U.S.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 82 U.S.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 83 U.S.: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 84 Canada: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 85 Canada: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 86 Canada: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 87 Canada: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 88 Canada: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 89 Canada: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 90 Canada: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 91 Canada: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 92 Europe: Rapid Diagnostics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 93 Europe: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 94 Europe: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 95 Europe: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 96 Europe: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 97 Europe: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 98 Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 99 Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 100 Europe: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 101 Recent Initiatives by the German Government to Tackle the Coronavirus Pandemic
• Table 102 Germany: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 103 Germany: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 104 Germany: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 105 Germany: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 106 Germany: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 107 Germany: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 108 Germany: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 109 Germany: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 110 U.K.: Number of Chlamydia Tests Conducted, 2018-2019
• Table 111 Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic
• Table 112 U.K.: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 113 U.K.: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 114 U.K.: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 115 U.K.: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 116 U.K.: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 117 U.K.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 118 U.K.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 119 U.K.: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 120 France: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 121 France: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 122 France: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 123 France: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 124 France: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 125 France: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 126 France: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 127 France: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 128 Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic
• Table 129 Italy: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 130 Italy: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 131 Italy: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 132 Italy: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 133 Italy: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 134 Italy: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 135 Italy: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 136 Italy: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 137 Spain: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 138 Spain: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 139 Spain: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 140 Spain: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 141 Spain: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 142 Spain: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 143 Spain: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 144 Spain: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 145 Rest of Europe: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 146 Rest of Europe: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 147 Rest of Europe: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 148 Rest of Europe: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 149 Rest of Europe: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 150 Rest of Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020-2029 (USD Million)
• Table 151 Rest of Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 152 Rest of Europe: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 153 Asia-Pacific: Rapid Diagnostics Market Size, by Country/Region, 2020-2029 (USD Million)
• Table 154 Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 155 Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 156 Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 157 Asia-Pacific: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 158 Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 159 Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020-2029 (USD Million)
• Table 160 Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 161 Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 162 China: Mass Testing Drives to Control the Spread of COVID-19 Infections
• Table 163 China: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 164 China: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 165 China: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 166 China: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 167 China: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 168 China: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 169 China: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 170 China: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 171 Japan: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 172 Japan: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 173 Japan: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 174 Japan: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 175 Japan: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 176 Japan: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 177 Japan: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 178 Japan: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 179 Recent Initiatives Launched by the Government of India to Combat the COVID-19 Pandemic
• Table 180 India: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 181 India: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 182 India: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 183 India: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 184 India: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 185 India: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 186 India: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 187 India: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 188 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 189 Rest of Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 190 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 191 Rest of Asia-Pacific: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 192 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 193 Rest of Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 194 Rest of Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 195 Rest of Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 196 Latin America: Number of New HIV Cases, by Country (2019)
• Table 197 Latin America: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 198 Latin America: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 199 Latin America: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 200 Latin America: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 201 Latin America: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 202 Latin America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020-2029 (USD Million)
• Table 203 Latin America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 204 Latin America: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 205 Middle East & Africa: Rapid Diagnostics Market Size, by Product, 2020-2029 (USD Million)
• Table 206 Middle East & Africa: Rapid Diagnostic Kits Market Size, by Type, 2020-2029 (USD Million)
• Table 207 Middle East & Africa: Rapid Diagnostics Market Size, by Platform, 2020-2029 (USD Million)
• Table 208 Middle East & Africa: Immunoassays Market Size, by Type, 2020-2029 (USD Million)
• Table 209 Middle East & Africa: Rapid Diagnostics Market Size, by Application, 2020-2029 (USD Million)
• Table 210 Middle East & Africa: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020-2029 (USD Million)
• Table 211 Middle East & Africa: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020-2029 (USD Million)
• Table 212 Middle East & Africa: Rapid Diagnostics Market Size, by End User, 2020-2029 (USD Million)
• Table 213 Recent Developments, by Company, 2018-2021

List of Figures

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Size Estimation
• Figure 7 Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2022 (USD Million)
• Figure 8 Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million)
• Figure 9 Global Rapid Diagnostics Market Size, By Application, 2029 Vs. 2022 (USD Million)
• Figure 10 Global Rapid Diagnostics Market Size, By End User, 2022 Vs. 2029 (USD Million)
• Figure 11 Global Rapid Diagnostics Market, By Geography
• Figure 12 Market Dynamics
• Figure 13 Global Percentage Share of The Population Aged 65 and Above (2010-2020)
• Figure 14 U.S.: Hepatitis A Virus (HAV) Infections (2013-2020)
• Figure 15 EU Regulatory Pathway - IVDR 2017/746
• Figure 16 Chinese Medical Device Classification and Pre-Market Requirements for Rapid Diagnostic Devices
• Figure 17 Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2029 (USD Million)
• Figure 18 Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million)
• Figure 19 Reverse Transcription-Polymerase Chain Reaction: Global Search Volume Index
• Figure 20 Global Rapid Diagnostics Market Size, By Application, 2022 Vs. 2029 (USD Million)
• Figure 21 U.S.: Estimated Acute Hepatitis C Cases, 2011-2020
• Figure 22 Estimated Number of New Cancer Cases, By Region, 2020-2040 (in Million)
• Figure 23 Total Number of Accredited Testing Laboratories (Iso/Iec 17025), 2016-2020
• Figure 24 Prevalence of Diabetes Across The World (in Million)
• Figure 25 Global Rapid Diagnostics Market Size, By End User, 2022-2029 (USD Million)
• Figure 26 U.S.: Home Healthcare Spending, 2015-2026 (USD Million)
• Figure 27 Global Rapid Diagnostics Market Size, By Region, 2022 Vs. 2029 (USD Million)
• Figure 28 North America: Rapid Diagnostics Market Snapshot
• Figure 29 U.S.: Number of HIV-Positive Patients, 2017-2020
• Figure 30 Canada: Number of People Aged 65 Years and Above, 2016-2020
• Figure 31 Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016-2020 (Per 1,00,000 Population)
• Figure 32 Europe: Rapid Diagnostics Market Snapshot
• Figure 33 U.K: Estimated Number of Cancer Cases, 2010-2030 (in Million)
• Figure 34 U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Disease Cases - DALYS (Disability-Adjusted Life Years), 2017 2020 (in Thousand)
• Figure 35 U.K.: Number of People Diagnosed With Sexually Transmitted Infections, 2018-2020 (in Thousand)
• Figure 36 France: Percentage of Population Aged 65 Years and Above, 2016-2020
• Figure 37 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
• Figure 38 Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016-2019
• Figure 39 Italy: Ovarian Cancer Cases Diagnosed, 2018-2020
• Figure 40 Italy: Total Number of New Diagnostic Laboratories for BRCA1/2 Testing, 2010-2019
• Figure 41 Number of Hiv Tests Performed in Catalonia (Spain), 2014-2020
• Figure 42 Asia-Pacific: Rapid Diagnostics Market Snapshot
• Figure 43 China: Independent Medical Laboratories Market, 2015-2019 (USD Million)
• Figure 44 Japan: Percentage Growth in The Aging Population (2015-2021)
• Figure 45 Key Growth Strategies Adopted By Leading Players (2018-2021)
• Figure 46 Rapid Diagnostics Market: Competitive Benchmarking
• Figure 47 Market Share Analysis: Rapid Diagnostics Industry (2021)
• Figure 48 Abbott Laboratories: Financial Overview (2021)
• Figure 49 Becton, Dickinson and Company: Financial Overview (2021)
• Figure 50 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
• Figure 51 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
• Figure 52 Danaher Corporation: Financial Overview (2021)
• Figure 53 Thermo Fisher Scientific Inc.: Financial Overview (2021)
• Figure 54 BioMerieux S.A.: Financial Overview (2020)
• Figure 55 Meridian Bioscience, Inc.: Financial Overview (2021)
• Figure 56 Trinity Biotech plc: Financial Overview (2020)

Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecasts to 2029

The global rapid diagnostics market is expected to grow at a CAGR of 1.4% from 2022-2029 to reach $26.40 billion by 2029.

Following a comprehensive primary and secondary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, and emerging technological innovations are the key factors driving the growth of the global rapid diagnostics market.

Further, the rising market potential in emerging economies, such as China and India, provides significant opportunities for existing market players and new entrants. The rising number of people suffering from non-communicable and infectious diseases, the growing population, and the rising urbanization are expected to provide significant growth opportunities in this region.

Based on product, the test readers/analyzers segment is expected to witness the fastest growth rate during the forecast period. The high growth rate of this segment is attributed to the capabilities of these devices to simultaneously read multiple tests in one scan and scale large volumes. In addition, healthcare facilities adopt analyzers for quick analysis compared to centralized lab analyzers due to their features, such as compact size, portability, and easy accessibility.

Based on platform, the molecular detection segment is expected to witness the fastest growth rate during the forecast period. The growth of this segment is attributed to the increasing popularity and awareness of molecular detection tests and the high demand for rapid PCR diagnostic kits due to the COVID-19 pandemic. For instance, according to google trends, the popularity and awareness of RT-PCR diagnostic tests in developing economies, such as India, the Philippines, and Brazil, have increased significantly recently due to the high demand for RT-PCR diagnostic kits for COVID-19 infection diagnosis. Also, various companies have launched PCR kits for qualitative and quantitative detection of COVID-19 infections. Some of the examples include:

• In February 2021, Bio-Rad Laboratories, Inc. (U.S.) launched the reliance SARS-CoV-2/FluA/FluB RT-PCR assay kit.
• In February 2021, Thermo Fisher Scientific Inc. (U.S.) launched the TaqPath COVID-19 RT-PCR Kit.
• In December 2020, F. Hoffmann-La Roche Ltd (Switzerland) launched the Elecsys SARS-CoV-2 Antigen test, a rapid detection test for diagnosing active COVID-19 infections.

Based on application, the tumor/cancer markers testing segment is expected to witness the fastest growth rate during the forecast period. The rising incidences of cancer amongst the general population is the major factor attributed to the growth of this segment. According to WHO, cancer was the leading cause of death globally in 2020, accounting for approximately 10 million deaths.

Furthermore, nearly 70% of deaths out of the total deaths from cancer occur in low- and middle-income countries; therefore, early detection is extremely important to reduce mortality, enhance survival, and save treatment costs. Thus, healthcare workers utilize various rapid diagnostic kits for the early detection of cancer.

Based on end user, the hospitals & clinics segment is expected to show the fastest growth rate during the forecast period. The large share of this segment is mainly attributed to the increasing demand for point-of-care diagnostics and the increasing healthcare expenditure worldwide, driving the demand for rapid diagnostic kits used in hospitals & clinics. Furthermore, the outbreak of the COVID-19 pandemic resulted in the increased demand for rapid diagnostic kits in hospitals & clinics for the treatment and prevention of COVID-19 infections.

An in-depth analysis of the geographical scenario of the rapid diagnostics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of the global rapid diagnostics market in 2022, followed by Asia-Pacific and Europe.

The key players operating in the global rapid diagnostics market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), BioMerieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report

Rapid Diagnostics Market, by Product

• Kits
• OTC Kits
• Professional Kits
• Test Readers/Analyzers

Rapid Diagnostics Market, by Platform

• Immunoassays
• Lateral Flow Assays
• Serological Assays
• Other Immunoassays
• Molecular Detection
• Polymerase Chain Reaction (PCR)
• Other Tests
• Other Platforms

(Note: Other Immunoassays include flow through immunoassays and agglutination assays; Other Tests include microfluidic and microarray devices; and Other platforms mainly include coagulation tests, glucose monitoring systems, dipsticks, and other rapid diagnostic platforms)

Rapid Diagnostics Market, by Application

• Blood Glucose Testing
• Cardiac Metabolism Testing
• Infectious Diseases Testing
• Influenza Testing
• HIV Testing
• Hepatitis Testing
• Sexually Transmitted Diseases (STD) Testing
• Healthcare Associated Infection (HAI) Testing
• Respiratory Disease Testing
• Tropical Disease Testing
• Other Infectious Disease Testing
• Coagulation Testing
• Pregnancy And Fertility Testing
• Fecal Occult Testing
• Hematology Testing
• Tumor/Cancer Markers Testing
• Drugs Of Abuse Testing
• Urinalysis
• Cholesterol Testing

(Note: Other infectious disease includes meningitis, norovirus [stomach flu], hand, foot and mouth disease [HFMD], and pertussis)

Rapid Diagnostics Market, by End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care/Self Testing
• Other End Users

Rapid Diagnostics Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Related Reports:

Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Analyzers, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecasts to 2028

Vaccines Market By Indication (Influenza, Rotavirus, DTP, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccines, Live Attenuated Vaccines), and Valence (Multivalent, Monovalent Vaccines) - Forecasts to 2028

Microscopy Market by Product (Microscopes, Software), Type [Optical (Compound, Digital), Electron (SEM, TEM), Scanning Probe (AFM, STM)], Application (Research, Material), and End User (Electronics, Healthcare, F&B, Academic) - Forecasts to 2028

Cardiac Pacemaker Devices Market by Product (Cardiac Pacemaker, Implantable Pacemakers, [Dual Chamber, CRT Pacemaker], External Pacemaker, Pacing Leads), Indication (Arrhythmia, CHF), End User (Hospital & Clinics, Ambulatory Care Centers) - Forecasts to 2028

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-up Approach
    • 2.3.1.2. Top-down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for this Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Market Overview
• 4.2. Drivers
  • 4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
  • 4.2.2. Growing Prevalence of Infectious Diseases
  • 4.2.3. Increasing Need for Rapid Decision-Making
  • 4.2.4. Growing Demand for Point-of-Care (POC) Diagnostics
  • 4.2.5. Technological Innovations
• 4.3. Restraints
  • 4.3.1. Variance in Test Results
• 4.4. Opportunities
  • 4.4.1. Emerging Markets
• 4.5. Challenges
  • 4.5.1. Reluctance Toward Changing Existing Diagnostic Practices
• 4.6. The Impact of COVID-19 on the Rapid Diagnostics Market
• 4.7. Regulatory Affairs Analysis
  • 4.7.1. U.S.
  • 4.7.2. Europe
  • 4.7.3. Asia-Pacific
  • 4.7.4. Latin America
  • 4.7.5. Middle East
• 4.8. Rapid Diagnostics: Innovations & Upcoming Technologies

5. Global Rapid Diagnostics Market, by Product

• 5.1. Introduction
• 5.2. Kits
  • 5.2.1. Professional Kits
  • 5.2.2. OTC Kits
• 5.3. Equipment

6. Global Rapid Diagnostics Market, by Platform

• 6.1. Introduction
• 6.2. Immunoassays
  • 6.2.1. Lateral Flow Assays
  • 6.2.2. Serological Tests
  • 6.2.3. Other Immunoassays
• 6.3. Molecular Detection Tests
• 6.4. Other Rapid Diagnostic Platforms

7. Global Rapid Diagnostics Market, by Application

• 7.1. Introduction
• 7.2. Infectious Diseases Testing
  • 7.2.1. COVID-19 Testing
  • 7.2.2. Healthcare-associated Infections (HAI) Testing
  • 7.2.3. Hepatitis Testing
    • 7.2.3.1. Hepatitis B
    • 7.2.3.2. Hepatitis C
  • 7.2.4. Tropical Diseases Testing
  • 7.2.5. HIV Testing
  • 7.2.6. Respiratory Diseases Testing (other than Influenza and COVID-19)
  • 7.2.7. Influenza Testing
  • 7.2.8. Sexually Transmitted Diseases (STD) Testing
  • 7.2.9. Other Infectious Diseases Testing
• 7.3. Pregnancy & Fertility Testing
• 7.4. Cardiac Metabolism Testing
• 7.5. Cholesterol Testing
• 7.6. Tumor/Cancer Markers Testing
• 7.7. Blood Glucose Testing
• 7.8. Urinalysis
• 7.9. Hematology Testing
• 7.10. Other Tests

8. Rapid Diagnostics Market, by End User

• 8.1. Introduction
• 8.2. Hospital & Clinics
• 8.3. Diagnostic Laboratories
• 8.4. Home Care/Self-testing
• 8.5. Other End Users

9. Rapid Diagnostics Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. U.K.
  • 9.3.3. France
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Market Share Analysis (2021)
  • 10.4.1. Abbott Laboratories (U.S.)
  • 10.4.2. Becton, Dickinson and Company (U.S.)
  • 10.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)

11. Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)

• 11.1. Abbott Laboratories
• 11.2. Becton, Dickinson and Company (BD)
• 11.3. Bio-Rad Laboratories, Inc.
• 11.4. F. Hoffmann-La Roche Ltd
• 11.5. ACON Laboratories, Inc.
• 11.6. Creative Diagnostics
• 11.7. Danaher Corporation
• 11.8. Thermo Fisher Scientific Inc.
• 11.9. BioMerieux S.A.
• 11.10. Alfa Scientific Designs, Inc.
• 11.11. BTNX Inc.
• 11.12. Meridian Bioscience, Inc.
• 11.13. Trinity Biotech plc

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization